Scientific Methodology and Practical Use of Managed Entry Agreements for Innovative Medicines in System of Health Technology Assessment in Ukraine

Farmatsevtychnyi zhurnal

doi 10.32352/0367-3057.4.19.04

Full Text

Abstract

Available in

Date

September 10, 2019

Authors

KH.-O. J. Stasiv

Publisher

The State Expert Center of the Ministry of Health of Ukraine

Related search

Psy188 - Use of Managed Entry Agreements in Inflammatory Disorders Among Key Health Technology Assessment Agencies

Value in Health

Occupational Health

English

What Principles Should Govern the Use of Managed Entry Agreements?

International Journal of Technology Assessment in Health Care

English

Adoption of Managed Entry Agreements in Established and Emerging Markets

Value in Health

Occupational Health

English

Php353 - Romanian Experience With Managed Entry Agreements for Drugs

Value in Health

Occupational Health

English

Managed Entry Agreements (MEA): Analysis of the Current Situation in Middle East and North Africa

Value in Health

Occupational Health

English

Php249 - Are Traditional Managed Entry Agreements Suitable for Potentially, Curative Gene/Cell Therapies?

Value in Health

Occupational Health

English

Managed Entry Agreements and Orphan Drugs: A European Comparative Study (2006-2012)

Value in Health

Occupational Health

English

Australian Managed Entry Scheme: A New Manageable Process for the Reimbursement of New Medicines?

Value in Health

Occupational Health

English

Potential Use of Routine Databases in Health Technology Assessment

Health Technology Assessment

English